Adaptive Biotechnologies ADPT Total costs & expenses
Total costs & expenses at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:CostsAndExpenses.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's total costs & expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's total costs & expenses?
- Adaptive Biotechnologies (ADPT) reported total costs & expenses of $90.08M in Q1 2026.
- How has Adaptive Biotechnologies's total costs & expenses changed year-over-year?
- Adaptive Biotechnologies's total costs & expenses increased by 9.8% year-over-year, from $82.05M to $90.08M.
- What is the long-term trend for Adaptive Biotechnologies's total costs & expenses?
- Over 4 years (2021 to 2025), Adaptive Biotechnologies's total costs & expenses has grown at a -2.1% compound annual growth rate (CAGR), from $363.31M to $334.1M.
- What does total costs & expenses mean?
- This metric represents the aggregate sum of all operating and non-operating costs incurred by the company to support its business activities, including cost of goods sold, research and development, and selling, general, and administrative expenses. It serves as a comprehensive measure of the total capital required to sustain operations and drive product development. Monitoring this figure allows investors to evaluate the company's overall cost structure and its ability to manage expenditures relative to revenue growth.